Trial · NCT03228680
Outcomes39
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 39
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Oocytes Retrieved | 36h (± 2h) after triggering of final follicular maturation (On day of oocyte retrieval) | The full analysis set (FAS) comprised all randomized and exposed participants. | Oocytes retrieved | MEAN |
| SECONDARY | Clinical Pregnancy Rate | 5-6 weeks after transfer (up to approximately 3 months after start of stimulation) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Positive Beta Unit of Human Chorionic Gonadotropin (Beta-hCG) Rate | 13-15 days after transfer (up to approximately 1.5 months after start of stimulation) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Vital Pregnancy Rate | 5-6 weeks after transfer (up to approximately 3 months after start of stimulation) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Implantation Rate | 5-6 weeks after transfer (up to approximately 3 months after start of stimulation) | The FAS comprised of all randomized and exposed participants with blastocyst transfer. | % of sacs/blastocysts transferred | NUMBER |
| SECONDARY | Proportion of Participants With Cycle Cancellation Due to Poor or Excessive Ovarian Response | End-of-stimulation (up to 20 stimulation days) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Proportion of Participants With Blastocyst Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | End-of-stimulation (up to 20 stimulation days) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | On the day of oocyte retrieval (up to 22 days after start of stimulation) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | On the day of oocyte retrieval (up to 22 days after start of stimulation) | The FAS comprised of all randomized and exposed participants. | percentage of participants | NUMBER |
| SECONDARY | Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | ≤9 days after triggering of final follicular maturation | The FAS comprised of all participants randomized or exposed. | percentage of participants | NUMBER |
| SECONDARY | Proportions of Participants With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | Up to 9 days after triggering of final follicular maturation | The FAS comprised of all participants randomized and exposed. | percentage of participants | NUMBER |
| SECONDARY | Proportions of Participants With Late OHSS (Including OHSS of Moderate/Severe Grade) | >9 days after triggering of final follicular maturation | The FAS comprised of all participants randomized or exposed. | percentage of participants | NUMBER |
| SECONDARY | Number of Follicles on Stimulation Day 6 | At Day 6 of stimulation | The FAS comprised of all randomized or exposed participants. | Follicles | MEAN |
| SECONDARY | Number of Follicles at End-of-stimulation | End-of-stimulation (up to 20 stimulation days) | The FAS comprised of all randomized or exposed participants. | Follicles | MEAN |
| SECONDARY | Size of Follicles on Stimulation Day 6 | At Day 6 of stimulation | The FAS comprised of all randomized and exposed participants | mm | MEAN |
| SECONDARY | Size of Follicles at End-of-Stimulation | End-of-stimulation (up to 20 stimulation days) | The FAS comprised of all randomized and exposed participants | mm | MEAN |
| SECONDARY | Fertilization Rate | Day 1 after oocyte retrieval (up to approximately 22 days after start of stimulation) | The FAS comprised all randomized and exposed participants | percentage of fertilized oocytes | MEAN |
| SECONDARY | Number and Quality of Embryos | Day 3 after oocyte retrieval (up to approximately 24 days after start of stimulation) | The FAS comprised of all randomized and exposed participants. | Embryo | MEAN |
| SECONDARY | Number and Quality of Blastocysts | Day 5 after oocyte retrieval (up to approximately 26 days after start of stimulation) | The FAS comprised of all randomized and exposed participants. | Blastocysts | MEAN |
| SECONDARY | Circulating Levels of Endocrine Parameters (Follicle-stimulating Hormone [FSH], Luteinising Hormone [LH]) on Stimulation Day 6 | At Day 6 of stimulation | The FAS comprised of all randomized and exposed participants. | IU/L | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03228680/outcomes